PRIFEN-01

A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of fenofibrate therapy on pancreatic beta-cell function in children and adolescents with newly diagnosed type 1 diabetes.

MULTICENTER, INTERVENTIONAL, DOUBLE-BLIND CLINICAL TRIAL

Dear Sir/Madam,

We invite you to participate in a non-commercial clinical trial aimed at investigating the efficacy and safety of orally administered fenofibrate in preserving residual pancreatic beta-cell function in children aged 10-17 years with newly diagnosed type 1 diabetes (T1D).

In case of technical issues, please contact:

BioStat Sp. z o.o.
Kowalczyka 17, 44-206 Rybnik
phone: 666 069 834
email: [email protected]